Condition
Partial Thickness Rotator Cuff Tear
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Terminated1
Recruiting1
Enrolling By Invitation1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05400798Not ApplicableEnrolling By InvitationPrimary
A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
NCT06414005Phase 2RecruitingPrimary
A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear
NCT03597490TerminatedPrimary
Multimodal Physical Therapy With Exercise in Partial-thickness Rotator Cuff Tears
NCT01123889Not ApplicableCompleted
Treatment of the Rotator Cuff Disease With Platelet Rich Plasma Injection
Showing all 4 trials